Core Points - The "zero tariff" import policy for medical devices and drugs in Hainan Boao Lecheng International Medical Tourism Pilot Zone has successfully facilitated the import of domestically listed medical devices, marking a significant milestone in the implementation of this tax incentive policy [1] - The policy allows for the exemption of import tariffs and value-added tax for registered medical institutions, medical education institutions, and pharmaceutical research institutes within the pilot zone, thereby enhancing the attractiveness of Hainan as a free trade port [1][2] Group 1 - The first successful import under the "zero tariff" policy involved a surgical microscope valued at 1.058 million yuan, resulting in a tax reduction of 137,500 yuan [1] - The policy covers two categories of medical devices: those not yet listed in China but available abroad, and those already listed domestically [1] - The implementation of this policy is expected to lower medical costs for patients and enhance the competitive edge of the free trade port by attracting advanced international medical technologies and products [1] Group 2 - As of June 2025, the cumulative import value under the "zero tariff" policy is projected to reach 130 million yuan, with tax reductions nearing 18 million yuan, indicating the growing impact of the policy [2] - The Boao Airport Customs is committed to promoting the policy and providing services to ensure that the benefits reach more medical institutions and patients [2]

Core Viewpoint - The introduction of a "zero tariff" policy for imported medical devices and drugs in the Boao Lecheng International Medical Tourism Pilot Zone is facilitating the rapid entry of advanced medical technologies and products, benefiting both domestic and international patients [2][3]. Group 1: Policy Implementation - The "zero tariff" policy for imported medical devices and drugs was officially implemented on December 25, 2024, following the issuance of management measures by the Hainan provincial government [3]. - The Lecheng Pilot Zone has successfully integrated multiple departments to streamline the application process for "zero tariff" imports, reducing the administrative burden on medical institutions [4][6]. Group 2: Clinical Applications - The first clinical use of the Nexa smart cochlear implant system occurred at the Tree Lan (Boao) Hospital, with 50 units purchased, valued at approximately 15 million yuan, resulting in over 1 million yuan in tax exemptions [2][4]. - As of July 5, 2024, approximately 50 surgeries have been completed using the Nexa system, showcasing the immediate impact of the new policy on patient care [2]. Group 3: Regulatory Innovations - A comprehensive tracking management platform has been established to facilitate the application for "zero tariff" imports, allowing medical institutions to submit requests without leaving the hospital [3][4]. - The platform has enabled real-time data sharing between customs and medical institutions, enhancing efficiency and reducing redundancy in the application process [4][6]. Group 4: Future Developments - Continuous optimization of the platform and mechanisms is planned to expand the range of eligible medical devices and drugs, aiming to maximize the benefits of the policy for a larger population [7].